| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |